BNB, the native cryptocurrency of BNB Chain, has continued its rally with another 8% upside on September 21. The BNB price is now trading at an all-time high of $1,088, with daily trading volumes surging 54% to $4.76 billion. Binance founder Changpeng Zhao recently shared the key factors behind this rally, adding that policy updates and chain upgrades have contributed to the rally. Is BNB Price Preparing for a Mega Rally Ahead? Over the weekend, BNB price staged a strong breakout above the $1,000 thresho ...

Group 1 - The individual investor focuses on managing personal capital accumulated over the years, utilizing a diverse range of investment strategies including fundamental, technical, and momentum investing [1] - The investor aims to leverage the strengths of various investment approaches to refine their investment process [1] - The purpose of writing on Seeking Alpha is to track the performance of investment ideas and connect with like-minded investors [1] Group 2 - There is no stock, option, or similar derivative position held by the analyst in any mentioned companies, nor are there plans to initiate such positions in the near future [2] - The article reflects the author's personal opinions and is not influenced by compensation from any company [2] - Seeking Alpha does not provide recommendations or advice regarding the suitability of investments for particular investors [3]

AMD is second fiddle to Nvidia in the largest computing buildout we've seen.Advanced Micro Devices (AMD -0.23%) hasn't had the best few years. It has been outshined by its rival Nvidia (NVDA 0.34%) in the biggest computing buildout of all time, and there doesn't appear to be a path where AMD can be a direct competitor with Nvidia. Instead, it's only viewed as an alternative so customers can push back against Nvidia if it gets too aggressive with pricing.Furthermore, AI hyperscalers are starting to design th ...

What sets TARA-002 apart is its novel approach. This cell therapy is derived from a cell bank of genetically distinct Streptococcus pyogenes, already approved in Japan as the broad immunopotentiator OK-432. The therapy works through a dual mechanism – directly killing tumor cells while also stimulating an immune response known as immunogenic cell death, thereby amplifying antitumor activity.The first penny stock we’ll look at is Protara Therapeutics, a clinical-stage biotech company focused on developing tr ...

Key Points Dogecoin can now be purchased in retirement accounts and brokerages. It's also being purchased by a new and deep-pocketed class of buyers. There are indications that big technology upgrades are in the works too. 10 stocks we like better than Dogecoin › For most of its time on the market, Dogecoin (CRYPTO: DOGE) has relied on a combination of hype and cultural cachet more than concrete mechanisms to pull in fresh capital. Today, there are three potential catalysts that might shake up th ...

Core Viewpoint - Tesla remains a polarizing investment, with significant volatility in its stock price influenced by various factors including CEO Elon Musk's recent stock purchase [1] Valuation Concerns - Over the past decade, Tesla shares have increased by 2,300%, driven by the company's innovative electric vehicle (EV) offerings and disruption of the global auto industry [3] - The current price-to-earnings (P/E) ratio stands at 246, indicating a high valuation that may deter potential investors and lead existing shareholders to consider selling [4] Financial Performance - In the second quarter, Tesla's automotive revenue experienced a 16% year-over-year decline, while operating income fell by 42%, highlighting challenges in the EV segment [5] Future Outlook - Investors are optimistic about Tesla's long-term prospects, betting on new ventures such as the Robotaxi business and humanoid robots to drive future sales and earnings, although the success of these initiatives is uncertain [6] - The stock has historically been speculative, and the current risk-reward profile is viewed as unfavorable at present valuation levels [7]

Ethereum co-founder Vitalik Buterin believes the network’s long-term sustainability may depend on an unlikely hero: low-risk decentralized finance protocols. Key Takeaways: Vitalik Buterin sees low-risk DeFi as a stable revenue source that could support Ethereum’s ecosystem without compromising its values. He likens it to Google Search, arguing it can fund Ethereum’s growth while keeping the network ideologically grounded. Buterin also advocates for basket currencies and flatcoins to reduce reliance ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Replimune Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Replimune securities class action is from November 22, 2024, to July 21, 2025 [1]. - Investors who purchased Replimune securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A lead plaintiff must file a motion with the Court by September 22, 2025, to represent other class members in the litigation [3]. Group 2: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements regarding the IGNYTE trial's prospects, which the FDA deemed inadequate [5]. - It is claimed that the defendants knew or should have known about material issues affecting the trial, leading to misleading statements about Replimune's business and operations [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Trade Relations - India's Commerce and Industry Minister, Piyush Goyal, is visiting the U.S. to discuss a "mutually beneficial" trade agreement aimed at resolving tariff tensions, particularly regarding U.S. tariffs on Indian goods and oil imports from Russia [2][4] - The U.S. has imposed a 50% tariff on most Indian goods and an additional 25% tariff on Russian crude oil purchases, significantly affecting Indian exporters in labor-intensive sectors [3][4] - The goal is to finalize a bilateral trade agreement by autumn 2025, with a target to increase bilateral trade from $191 billion to $500 billion by 2030 [4] H-1B Visa Policy - A new executive order by U.S. President Donald Trump imposes a $100,000 one-time fee for H-1B worker visas, causing confusion among visa holders, particularly from India and China [5][6] - Major tech firms have advised employees to return to the U.S. before the deadline due to fears of potential re-entry restrictions [5][6] - The administration claims the H-1B program has been exploited to lower wages, while supporters argue it is essential for attracting skilled talent [6] Automotive Industry - Mitsubishi Motors achieved a significant victory in the Asia Cross Country Rally 2025, outperforming Toyota despite budget constraints [10][11] - This win marks Mitsubishi's first rally triumph in three years and highlights the company's strategic improvements under financial pressures [11]

Michael Saylor, executive chairman of Strategy, claims that the company’s harshest critics aren’t retail investors or analysts, but a coordinated network of bots funded by short sellers. Key Takeaways: Michael Saylor claims short sellers are using paid bot networks to amplify criticism against Strategy. Strategy’s stock has dropped to a five-month low despite only a modest decline in Bitcoin’s price. Veteran short seller Jim Chanos dismissed Saylor’s claims and renewed criticism of Strategy’s leverag ...